We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUXA
776
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
-950,858
Closed -$9.52M
LUXAW
777
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
-6,012
Closed -$1K
PAQC
778
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
-890,265
Closed -$8.88M
PAQCW
779
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
-154
Closed
PAQCU
780
DELISTED
Provident Acquisition Corp. Units
PAQCU
-948
Closed -$10K
SRSAW
781
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
-5,968
Closed
SRSA
782
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
-2,858,803
Closed -$28.6M
TEKK
783
DELISTED
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
-2,484,281
Closed -$24.9M
BLSA
784
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
-1,203,093
Closed -$12.1M
LFTR
785
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
-1,446,707
Closed -$14.5M
HIGA
786
DELISTED
H.I.G. Acquisition Corp.
HIGA
-3,614,118
Closed -$36.3M
CCXI
787
DELISTED
ChemoCentryx, Inc.
CCXI
-791,932
Closed -$40.9M
MN
788
DELISTED
MANNING & NAPIER, INC.
MN
-930,972
Closed -$11.4M
TMPM
789
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
-945,630
Closed -$9.46M
AVLR
790
DELISTED
Avalara, Inc.
AVLR
-1,621,191
Closed -$149M
PING
791
DELISTED
Ping Identity Holding Corp.
PING
-2,742,019
Closed -$77M
IPOD
792
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
-3,961,829
Closed -$39.7M
IPOF
793
CALL
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
-2,112
Closed -$7K
IPOF
794
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
-11,168,428
Closed -$112M
FMTX
795
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
-607,345
Closed -$12.1M
CVET
796
DELISTED
Covetrus, Inc. Common Stock
CVET
-3,470,802
Closed -$72.5M
TPGY
797
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
-3,822,935
Closed -$38.3M
IEA
798
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-2,333,895
Closed -$31.6M
RCHG
799
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
-611,962
Closed -$6.19M
AVAN
800
DELISTED
Avanti Acquisition Corp.
AVAN
-5,985,000
Closed -$60M

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.